Melanoma Risks and Risk Prediction in Patients with Actinic Keratosis by Adam Smartt | Dec 31, 2021 | Career Development Award, Featured
Harnessing Epigenetic therapies to License Melanoma Vaccine by Adam Smartt | Dec 31, 2021 | Career Development Award
Targeting metabolic vulnerabilities of melanoma metastasis in lymph by Adam Smartt | Dec 31, 2021 | Career Development Award
Immunotherapy using personalized T cell receptor engineered T cells by Adam Smartt | Dec 31, 2021 | Career Development Award, Donor Directed
Analysis and Expansion of the Pediatric Melanoma Outcomes Database Study by Adam Smartt | Dec 31, 2021 | Career Development Award
Therapeutic Resistance to CDK4/6 inhibitors in BRAF-mutant Melanoma by Adam Smartt | Dec 31, 2021 | Career Development Award, Featured
Recent Comments